[Experimental and clinical studies on cancer chemotherapy--enhancement of the cytocidal effect of Mitomycin-C by one of lysosome labilizer, plasmin].
D000135:Acid Phosphatase / Q000032:analysis; D000818:Animals; D003851:Deoxyribonucleases / Q000032:analysis; D004357:Drug Synergism; D005341:Fibrinolysin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005966:Glucuronidase / Q000032:analysis; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology*; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy / Q000201:enzymology
D008937:Mitomycins; D003851:Deoxyribonucleases; D000135:Acid Phosphatase; D005966:Glucuronidase; D005341:Fibrinolysin